Effectiveness and Safety of Sacubitril/Valsartan for Heart Failure with Reduced Ejection Fraction Secondary to Duchenne Muscular Dystrophy-Associated Cardiomyopathy

In individuals with an ejection fraction of 40% or less, the use of sacubitril/valsartan significantly lowers mortality or hospitalization. There has been no research related to the effectiveness and safety of sacubitril/valsartan in patients with Duchenne muscular dystrophy (DMD)-associated cardiom...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Pankaj Jariwala, Kartik Jadhav, Saket Khetan
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Wolters Kluwer Medknow Publications 2023-01-01
Serie:	Journal of the Indian Academy of Echocardiography & Cardiovascular Imaging
Soggetti:	angiotensin antagonist dilated cardiomyopathy heart failure with reduced ejection fraction muscular dystrophy
Accesso online:	http://www.jiaecho.org/article.asp?issn=2543-1463;year=2023;volume=7;issue=1;spage=31;epage=36;aulast=Jariwala
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!